• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Mix and match = better patient satisfaction

Article

Mixing and matching the ReZoom (AMO) and Tecnis (AMO) multifocal intraocular lenses (IOLs) produces enhanced visual outcomes and patient satisfaction.

Mixing and matching the ReZoom (AMO) and Tecnis (AMO) multifocal intraocular lenses (IOLs) produces enhanced visual outcomes and patient satisfaction, according to Baha Toygar and colleagues from the Dunya Eye Hospital, Istanbul, Turkey.

In a concurrent case series, 11 refractive lens exchange (RLE) patients and three cataract patients were bilaterally implanted with ReZoom in the dominant eye and Tecnis in the fellow eye. One subject with high hyperopia underwent a piggyback IOL implantation. The target refraction for both multifocal IOLs was emmetropia.

At six-month follow-up, mean postoperative spherical equivalent (SE) was -0.11±0.47 D. Monocular uncorrected and best corrected distance visual acuity (VA) was 0.78±0.21 and 0.95±0.16, respectively. All patients, except for the patient receiving the piggyback implantation, could read 20/20 binocularly. Eighty-two percent of subjects achieved a near uncorrected VA of J2 or better and, when tested binocularly without correction, 100% of patients could read J2 or better, including 65% who achieved J1 or better. None of the patients reported halos or glare.

The researchers concluded from their study that the combination of the two lenses leads to enhanced visual outcomes and patient satisfaction.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.